Wright M, Chawla H, Adams A
Princess Alexandra Eye Pavilion, Edinburgh.
Br J Ophthalmol. 1999 Jan;83(1):71-5. doi: 10.1136/bjo.83.1.71.
To assess the efficacy of extracapsular cataract surgery using the anterior chamber maintainer (ACM) without the use of viscoelastic. To compare the effects of this surgical technique on non-diabetic and diabetic patients.
A prospective single armed clinical trial of 46 eyes in 46 patients undergoing cataract surgery using the ACM without viscoelastic. Patients were assessed preoperatively and at 3 weeks, 3 months, and 12 months postoperatively. The main outcome variables included visual acuity, surgically induced astigmatic change (SIAC), changes in endothelial cell density (ECD), and morphology affecting the central and superior regions of the cornea.
Postoperatively, 56% and 70% of patients had unaided visual acuities of 6/12 or better at 3 weeks and 3 months respectively. Even after excluding those patients with pre-existing maculopathy (including diabetic maculopathy), there remains a significant difference between the non-diabetic and diabetic groups in terms of the proportion of patients attaining an unaided visual acuity of 6/12 or better at both 3 weeks (p = 0.003) and 3 months (p = 0.001). Three months postoperatively, the SIAC based upon the keratometric and refractive data was 1.1 dioptres (D) and 1.3 D respectively. There was no statistically significant difference in the SIAC when the non-diabetic and diabetic groups were compared. The mean central and superior endothelial cell losses at 3 months postoperatively were 16% and 22% respectively and at 12 months postoperatively were 20% and 25% respectively. The diabetic group demonstrated greater endothelial cell losses and a more marked and protracted deviation of endothelial cell morphology from normality when compared with the non-diabetic group; however, the differences did not reach statistical significance.
The efficacy of small incision cataract surgery using the ACM in terms of visual outcome and induced astigmatism is comparable with the results obtained using other techniques that utilise a similar size of incision. However, in view of the magnitude and range of the endothelial cell losses associated with this technique the concurrent use of viscoelastic is suggested. There does not appear to be a statistically or clinically significant difference between non-diabetic and diabetic patients in terms of the magnitude of the endothelial cell losses or in the wound healing response in the 12 months after cataract surgery using the ACM.
评估在不使用粘弹性物质的情况下,使用前房维持器(ACM)进行白内障囊外摘除术的疗效。比较该手术技术对非糖尿病患者和糖尿病患者的影响。
一项前瞻性单臂临床试验,对46例患者的46只眼睛进行不使用粘弹性物质的ACM白内障手术。在术前以及术后3周、3个月和12个月对患者进行评估。主要观察变量包括视力、手术诱导的散光变化(SIAC)、内皮细胞密度(ECD)的变化以及影响角膜中央和上方区域的形态。
术后,分别有56%和70%的患者在3周和3个月时的裸眼视力达到6/12或更好。即使排除那些术前就存在黄斑病变(包括糖尿病性黄斑病变)的患者,非糖尿病组和糖尿病组在3周(p = 0.003)和3个月(p = 0.001)时达到裸眼视力6/12或更好的患者比例仍存在显著差异。术后3个月,根据角膜曲率计和屈光数据得出的SIAC分别为1.1屈光度(D)和1.3 D。比较非糖尿病组和糖尿病组时,SIAC没有统计学上的显著差异。术后3个月时,中央和上方内皮细胞平均损失分别为16%和22%,术后12个月时分别为20%和25%。与非糖尿病组相比,糖尿病组内皮细胞损失更大,内皮细胞形态偏离正常的程度更明显且持续时间更长;然而,差异未达到统计学意义。
就视觉效果和诱导散光而言,使用ACM进行小切口白内障手术的疗效与使用类似切口大小的其他技术所获得的结果相当。然而,鉴于与该技术相关的内皮细胞损失的程度和范围,建议同时使用粘弹性物质。在使用ACM进行白内障手术后的12个月内,非糖尿病患者和糖尿病患者在内皮细胞损失程度或伤口愈合反应方面似乎没有统计学或临床意义上的显著差异。